Epidemiology and 10-year clinical care of juvenile myasthenia gravis in England: a retrospective cohort study
Authors:
Open Access
- 1 January 2025
- journal article
- Published by BMJ in BMJ Neurology Open
- Vol. 7 (1) , e001000
Abstract
Background: Published evidence is limited on the clinical burden of juvenile myasthenia gravis (JMG). We aimed to assess epidemiology and the clinical characteristics of JMG in England. Methods: We performed a retrospective analysis of patients with newly diagnosed JMG identified in England via primary care and hospital data between 2010 and 2019. Results: 32 children (aged 2–17 years) with newly diagnosed JMG were included. Prevalence of JMG ranged from 2.2 (95% CI 1.5 to 3.1) in 2012 to 2.5 (95% CI 1.8 to 3.4) per 100 000 in 2018. The annual incidence ranged from 0.8 (95% CI 0.1 to 5.7) in 2015 to 3.8 (95% CI 1.6 to 9.0) per million per year in 2017. Incidence fluctuated in females from 1.6 (95% CI 0.2 to 11.3) in 2016 to 6 (95% CI 2.3 to 16.1) per million per year in 2018. Overall, 20 patients received first acetylcholinesterase inhibitors or corticosteroids with no prior therapy during the study period. During the follow-up period (median, 3.3 years), 17 patients (53.1%) with JMG experienced a hospitalisation. No deaths were observed. Conclusions: This study confirms the rarity of JMG in England, with steady incidence and prevalence rates over a decade. Further research is required to assess unmet needs in JMG therapy and the importance of effective treatments for this condition.Keywords
This publication has 12 references indexed in Scilit:
- Epidemiology of myasthenia gravis in Denmark, Finland and Sweden: a population-based observational studyJournal of Neurology, Neurosurgery & Psychiatry, 2024
- Treatment patterns in myasthenia gravis: A United States health claims analysisMuscle & Nerve, 2023
- A retrospective longitudinal cohort study of the clinical burden in myasthenia gravisBMC Neurology, 2022
- Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disordersThe Lancet Neurology, 2022
- 242nd ENMC International Workshop: Diagnosis and management of juvenile myasthenia gravis Hoofddorp, the Netherlands, 1–3 March 2019Neuromuscular Disorders, 2020
- Interpretation and Impact of Real-World Clinical Data for the Practicing ClinicianAdvances in Therapy, 2018
- Juvenile myasthenia gravis in Norway: A nationwide epidemiological studyEuropean Journal of Paediatric Neurology, 2017
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)International Journal of Epidemiology, 2015
- How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myastheniaArchives of Disease in Childhood, 2014
- Nationwide Population-Based Epidemiological Study of Myasthenia Gravis in TaiwanNeuroepidemiology, 2010